Cargando…

Serotype changes and antimicrobial nonsusceptibility rates of invasive and non-invasive Streptococcus pneumoniae isolates after implementation of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Bulgaria

The 10-valent pneumococcal conjugate vaccine (PCV10) has been included in Bulgarian Childhood Immunization Program since 2010. This study aimed to assess serotype distribution and antimicrobial resistance of 198 invasive and non-invasive Streptococcus pneumoniae strains that had been isolated in Bul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Setchanova, Lena, Murdjeva, Marianna, Stancheva, Iglika, Alexandrova, Alexandra, Sredkova, Maria, Stoeva, Temenuga, Yoneva, Magda, Kurchatova, Anna, Mitov, Ivan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428030/ https://www.ncbi.nlm.nih.gov/pubmed/28472614 http://dx.doi.org/10.1016/j.bjid.2017.03.011

Ejemplares similares

Immunogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) co-administered with DTPa vaccine in Japanese children: A randomized, controlled study
por: Iwata, Satoshi, et al.
Publicado: (2015)

Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media—A Double-Blind Randomized Clinical Trial in Finland
por: Vesikari, Timo, et al.
Publicado: (2016)

Safety and immunogenicity of 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian children: Booster dose and 2-dose catch-up regimens in the second year of life
por: Odusanya, Olumuyiwa O, et al.
Publicado: (2014)

Dissemination of High-Risk Clones Enterobacterales among Bulgarian Fecal Carriage Isolates
por: Markovska, Rumyana, et al.
Publicado: (2022)

First report of rhino-orbital-cerebral mucormycosis after COVID-19 infection in Bulgaria
por: Niyazi, Denis, et al.
Publicado: (2022)

Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
por: Tregnaghi, Miguel W., et al.
Publicado: (2014)

Correction: Efficacy of Pneumococcal Nontypable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) in Young Latin American Children: A Double-Blind Randomized Controlled Trial
por: Tregnaghi, Miguel W., et al.
Publicado: (2015)

Effects of Vaccination with 10-Valent Pneumococcal Non-Typeable Haemophilus influenza Protein D Conjugate Vaccine (PHiD-CV) on the Nasopharyngeal Microbiome of Kenyan Toddlers
por: Feazel, Leah M., et al.
Publicado: (2015)

A 6-year safety surveillance of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in South Korea
por: Lee, Soon Min, et al.
Publicado: (2018)

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
por: Dicko, Alassane, et al.
Publicado: (2013)

10‐valent pneumococcal non‐typeable Haemophilus influenzae protein‐D conjugate vaccine (PHiD‐CV) induces memory B cell responses in healthy Kenyan toddlers
por: Muema, D. M., et al.
Publicado: (2015)

Invasive Disease Caused by Nontypeable Haemophilus influenzae
por: Langereis, Jeroen D., et al.
Publicado: (2015)

Primary vaccination with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial
por: Dicko, Alassane, et al.
Publicado: (2011)

Cost-effectiveness analysis of infant pneumococcal vaccination with PHiD-CV in Korea
por: Zhang, Xu-Hao, et al.
Publicado: (2017)

Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in Greenland
por: Nikolova, Kristiana Alexandrova, et al.
Publicado: (2021)

Quinolone resistance mechanisms among third-generation cephalosporin resistant isolates of Enterobacter spp. in a Bulgarian university hospital
por: Markovska, Rumyana, et al.
Publicado: (2019)

A Cost-Effectiveness Analysis of the 10-Valent Pneumococcal Non-Typeable Haemophilus influenzae Protein D Conjugate Vaccine (PHiD-CV) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) for Universal Mass Vaccination Implementation in New Zealand
por: Varghese, Lijoy, et al.
Publicado: (2018)

Pneumonia hospitalizations and mortality in children 3 – 24-month-old in Nigeria from 2013 to 2020: Impact of pneumococcal conjugate vaccine ten valent (PHiD-CV-10)
por: Iliya, Jalo, et al.
Publicado: (2023)

Microbiological characterization of Streptococcus pneumoniae and non-typeable Haemophilus influenzae isolates as primary causes of acute otitis media in Bulgarian children before the introduction of conjugate vaccines
por: Setchanova, Lena P, et al.
Publicado: (2013)

Severity of Invasive Pneumococcal Disease in Children Caused by Susceptible and Nonsusceptible Isolates
por: Iroh Tam, Pui-Ying, et al.
Publicado: (2014)

A randomised trial to evaluate the immunogenicity, reactogenicity, and safety of the 10-valent pneumococcal non-typeable Haemophilus influenzaeprotein D conjugate vaccine (PHiD-CV) co-administered with routine childhood vaccines in Singapore and Malaysia
por: Lim, Fong Seng, et al.
Publicado: (2014)

Invasive pulmonary co-infection caused by Aspergillus sp. and Pneumocystis jirovecii, complicated by Cytomegalovirus reactivation in a patient following second allogeneic hematopoietic stem cell transplantation – Case report
por: Niyazi, Denis, et al.
Publicado: (2023)

Severity of Invasive Pneumococcal Disease in Children Caused by Susceptible and Nonsusceptible Isolates: ERRATUM
Publicado: (2015)

Q fever in Bulgaria: Laboratory and epidemiological findings on human cases and outbreaks, 2011 to 2017
por: Genova-Kalou, Petia, et al.
Publicado: (2019)

The Effect of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine on H. influenzae in Healthy Carriers and Middle Ear Infections in Iceland
por: Sveinsdóttir, Hildigunnur, et al.
Publicado: (2019)

Primary immunodeficiencies in Bulgaria - achievements and challenges of the PID National Expert Center
por: Naumova, Elissaveta, et al.
Publicado: (2022)

Pilot Study on the Cost of Some Oncohematology Diseases in Bulgaria
por: Tachkov, Konstantin, et al.
Publicado: (2019)

Effects of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D–Conjugate Vaccine on Nasopharyngeal Bacterial Colonization in Young Children: A Randomized Controlled Trial
por: van den Bergh, Menno R., et al.
Publicado: (2013)

Genomic differences among carriage and invasive nontypeable pneumococci circulating in South Africa
por: Mohale, Thabo, et al.
Publicado: (2019)

phiD12-Like Livestock-Associated Prophages Are Associated With Novel Subpopulations of Streptococcus agalactiae Infecting Neonates
por: Renard, Adélaïde, et al.
Publicado: (2019)

Safety, reactogenicity and immunogenicity of 2-dose catch-up vaccination with 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children in the second year of life: Results from an open study
por: Dicko, Alassane, et al.
Publicado: (2015)

Summary of WG7 at CKM 2018: "Mixing and $CP$ violation in the $D$ system: $x_D$, $y_D$, $|q/p|_D$, $\phi_D$, and direct $CP$ violation in $D$ decays"
por: Bhardwaj, Vishal, et al.
Publicado: (2019)

Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy
por: Castiglia, Paolo, et al.
Publicado: (2017)

Predominance of influenza B/Yamagata lineage viruses in Bulgaria during the 2017/2018 season
por: Korsun, N. S., et al.
Publicado: (2019)

Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018–2019 winter season
por: Korsun, Neli, et al.
Publicado: (2020)

Chronic Hepatitis C-Related Cirrhosis Hospitalization Cost Analysis in Bulgaria
por: Dimitrova, Maria, et al.
Publicado: (2017)

10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised controlled trial
por: Oguoma, Victor M, et al.
Publicado: (2020)

Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia
por: Wang, Xiao Jun, et al.
Publicado: (2017)

Exploring the evidence behind the comparable impact of the pneumococcal conjugate vaccines PHiD-CV and PCV13 on overall pneumococcal disease
por: Izurieta, Patricia, et al.
Publicado: (2021)

A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia
por: Lagoubi, Youness, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jdrjdnjm58stfs44623q2pee6d